Alkaline phosphatase for reducing systemic inflammatory response syndrome (SIRS) in patients with Sars-CoV-2 infection and acute respiratory insufficiency (COVID 19) : Alkaline phosphatase for reducing systemic inflammatory response syndrome (SIRS) in patients with Sars-CoV-2 infection and acute respiratory insufficiency (COVID 19)

Medienart:

Klinische Studie

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

WHO International Clinical Trials Registry Platform - (2021) vom: 01. März Zur Gesamtaufnahme - year:2021

Sprache:

Unbestimmt

Links:

Volltext [kostenfrei]

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), Registered on 02/05/2020, Last updated on 2021-05-10

ICTRP ID:

NL8578

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

CTG007181264